Larissa leads the way in treating human parainfluenza virus

Griffith Sciences
Pre-clinical trials are being planned on a treatment for human parainfluenza virus discovered by the Institute for Glycomics. This treatment could be the first on the market to treat the virus, which causes lower respiratory infections, such as bronchiolitis, pneumonia or croup. A team at the Institute lead by Director Mark von Itzstein has for […]